IL33 and neoplasm: Tumor-rather than host-derived IL-33 directed the recruitment of CD11b+ Gr1+ MDSCs and CD11b+ F4/80+ macrophages [68] as well as CD117+ FcRεγ+ mast cells (Pena et al., unpublished data and [71]) into the tumor beds to remodel the TME and promote growth, invasion, angiogenesis, and metastasis.